NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

If you add to the equation all the trials on DC vaccine therapy conducted by Mayo Clinic, then everything makes sense. Merck didn't build these vaccine manufacturing facilities for short term. Note that Building 63A is for pre-filled syringe of pneumococcal vaccine. WP50 has other immune boosters as elaborated in Dr. Caravello's analysis.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176458711

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma
Phase I/II Study of Dendritic Cell Therapy Delivered Intratumorally After Cryoablation and Anti-PD-1 Antibody (Pembrolizumab) for Patients With Non-Hodgkin Lymphoma

https://clinicaltrials.gov/study/NCT03035331

https://clinicaltrials.gov/study/NCT03035331?tab=results&a=23&b=24&compareMode=sideBySide

Study Start (Actual):2017-08-15
Primary Completion (Actual): 2022-01-25
Principal Investigator:Yi Lin, MD, PhD,Mayo Clinic

2022
https://openpaymentsdata.cms.gov/payment/2022/research/940392359

2020
https://openpaymentsdata.cms.gov/payment/2020/research/740778379
https://openpaymentsdata.cms.gov/payment/2020/research/740778383
https://openpaymentsdata.cms.gov/payment/2020/research/740778385

2019
https://openpaymentsdata.cms.gov/payment/2019/research/691435219

2018
https://openpaymentsdata.cms.gov/payment/2018/research/607117463
https://openpaymentsdata.cms.gov/payment/2018/research/607019675